Biotage AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 395 million compared to SEK 303 million a year ago. Net income was SEK 57 million compared to SEK 46 million a year ago. Basic earnings per share from continuing operations was SEK 0.87 compared to SEK 0.71 a year ago. Diluted earnings per share from continuing operations was SEK 0.87 compared to SEK 0.7 a year ago.
For the six months, sales was SEK 781 million compared to SEK 585 million a year ago. Net income was SEK 129 million compared to SEK 106 million a year ago. Basic earnings per share from continuing operations was SEK 1.95 compared to SEK 1.63 a year ago. Diluted earnings per share from continuing operations was SEK 1.95 compared to SEK 1.62 a year ago.